Article Examines Coverage of Biosimilars

May 26, 2020

A recent article published in JAMA examines how commercial health plans cover biosimilars compared to their reference products.

While Congress in 2010 approved a quicker pipeline for biosimilars, the authors write, “it is unclear whether and how health plans prioritize coverage of these products.”

To read the article, click here. (Paid subscription required)

Share This Story!